Entity
Company
Location
950 Third Avenue, Fl 25, New York, NY
Signature
Puissance Life Science Opportunities Fund VI, By: Puissance Capital Fund (GP) LLC, its managing member, By: Theodore T. Wang, Managing Member
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Puissance Life Science Opportunities Fund VI:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Bellerophon Therapeutics, Inc. 10%+ Owner Common Stock 1.08M $112K $0.10 Jun 7, 2023 Direct

Insider Reports Filed by Puissance Life Science Opportunities Fund VI

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BLPH Bellerophon Therapeutics, Inc. Jun 7, 2023 1 -$112K 4 Jun 7, 2023 10%+ Owner
BLPH Bellerophon Therapeutics, Inc. May 18, 2023 1 -$5.3M 4 May 19, 2023 10%+ Owner
BLPH Bellerophon Therapeutics, Inc. Jun 7, 2021 1 $32.8K 4 Jun 8, 2021 10%+ Owner